According to Xenetic Biosciences's latest financial reports the company has a price-to-book ratio of 0.5584.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.5426 | 71.26% |
2022-12-31 | 0.3168 | -66.38% |
2021-12-31 | 0.9425 | -35.46% |
2020-12-31 | 1.46 | 187.82% |
2019-12-31 | 0.5074 | -67.39% |
2018-12-31 | 1.56 | 33.04% |
2017-12-31 | 1.17 | -46.95% |
2016-12-31 | 2.20 | -81.13% |
2015-12-31 | 11.7 | 251.47% |
2014-12-31 | 3.32 | -136.66% |
2013-12-31 | -9.06 | |
2012-12-31 | N/A |